...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >BTZO-2, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice
【24h】

BTZO-2, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice

机译:BTZO-2是一种抗氧化反应元素激活剂,可防止小鼠致命的内毒素性休克

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We recently reported a unique antioxidant response element (ARE)-activator, BTZO-1, which induced expression of cytoprotective proteins such as heme oxygenase-1 (HO-1) and suppressed oxidative stress-induced cardiomyocyte apoptosis via binding to macrophage migration inhibitory factor (MIF). HO-1 induction and apoptosis inhibition have been reported to improve the outcomes following experimental sepsis by protecting the organs. Therefore, we investigated the potential of BTZO-2, an active BTZO-1 derivative, as a drug for sepsis. BTZO-2 significantly protected mice from the endotoxic shock induced by 5 mg/kg lipopolysaccharide (LPS); survival rates increased from 42% to 100%. In contrast, BTZO-2 did not provide significant protection to mice from the shock induced by 10 ??g/kg LPS together with d-galactosamine (d-GalN, hepatocyte-specific transcription inhibitor) (LPS/d-GalN). Hepatic HO-1 protein was up-regulated by BTZO-2 in mice injected with 5 mg/kg LPS, but not in those injected with 10 ??g/kg LPS/d-GalN. Interestingly, BTZO-2 showed little or no effect on LPS-induced up-regulation of plasma cytokine levels in mice. Thus, the organ protection mediated by HO-1 may have a pivotal role in the pharmacological effect of BTZO-2. These results suggest that BTZO-2 is a promising compound for a novel drug for sepsis. ? 2012 Elsevier B.V.
机译:我们最近报道了一种独特的抗氧化反应元件(ARE)活化剂BTZO-1,它通过与巨噬细胞迁移抑制因子结合而诱导细胞保护蛋白(如血红素加氧酶-1(HO-1))的表达并抑制氧化应激诱导的心肌细胞凋亡。 (MIF)。据报道,HO-1的诱导和凋亡抑制可通过保护器官改善实验性脓毒症的预后。因此,我们研究了活性ZOZO-1衍生物BTZO-2作为败血症药物的潜力。 BTZO-2可显着保护小鼠免受5 mg / kg脂多糖(LPS)诱导的内毒素性休克的侵害;生存率从42%增加到100%。相反,BTZO-2不能为小鼠提供明显的保护,使其免受10 ?? g / kg LPS和d-半乳糖胺(d-GalN,肝细胞特异性转录抑制剂)(LPS / d-GalN)诱导的休克的影响。 BTZO-2在注射5 mg / kg LPS的小鼠中肝脏HO-1蛋白被上调,但在注射10μg/ kg LPS / d-GalN的小鼠中则没有。有趣的是,BTZO-2对LPS诱导的小鼠血浆细胞因子水平上调几乎没有或没有影响。因此,HO-1介导的器官保护可能在BTZO-2的药理作用中起关键作用。这些结果表明,BTZO-2是用于脓毒症新药的有前途的化合物。 ? 2012年Elsevier B.V.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号